Mashup Score: 8
American College of CardiologyImplantable cardiac monitoring (ICM) of high-risk patients who had suffered a myocardial infarction (MI) did not reduce future cardiovascular events overall, but benefit was seen in NSTEMI patients compared with STEMI patients, according to the results of the BIO|GUARD-MI study presented April 4 at ACC.22. The trial was stopped earlier than anticipated because of an unexpectedly high...
-
123456